title: Effect of multiple doses of clarithromycin and amoxicillin on IL-6, IFNgamma and IL-10 plasma levels in patients with community acquired pneumonia.
abstract: Inflammation is crucial for the pathogenesis of both infectious and chronic obstructive pulmonary diseases. It is therefore important to modulate pulmonary inflammation in patients with these lung disorders. Macrolide antibiotics modulate inflammation in vitro and in in vivo by inhibiting the production of proinflammatory cytokines and prostaglandin E2, neutrophil chemotactic activity and elastase activity. This study evaluates the effect of clarithromycin (500 mg b.i.d. x 7 days) in comparison to amoxicillin (1 g t.i.d. x 7 days) in patients with community acquired pneumonia by testing plasma levels of IL-6, IFNgamma and IL-10 before starting therapy and at the 3rd and 7th days of therapy. Clarithromycin significantly decreased plasma levels of IL-6 and significantly increased those of IFNgamma and IL-10 at the 3rd and 7th day in comparison to basal levels. In patients treated with amoxicillin a significant decrease in IL-6 plasma levels was observed at the 7th day of therapy, probably in relation to the resolution of inflammatory symptoms. In the same patients IFNgamma plasma levels decreased during treatment while IL-10 plasma levels were unaffected.
authors.affiliation: Dept. of Pharmacology, University of Milan, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Demartini
authors.forename: D
authors.initials: D
authors.lastname: Esposti
authors.forename: P
authors.initials: P
authors.lastname: Marthyn
authors.forename: A
authors.initials: A
authors.lastname: Lapidari
authors.forename: F
authors.initials: F
authors.lastname: Fraschini
authors.forename: F
authors.initials: F
authors.lastname: Scaglione
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D017291:Clarithromycin / Q000008:administration & dosage / Q000494:pharmacology*; D017714:Community-Acquired Infections; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000097:blood*; D016753:Interleukin-10 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010406:Penicillins / Q000008:administration & dosage / Q000494:pharmacology*; D011014:Pneumonia / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D015850:Interleukin-6; D010406:Penicillins; D016753:Interleukin-10; D000658:Amoxicillin; D007371:Interferon-gamma; D017291:Clarithromycin